China · Delayed Price · Currency is CNY Chongqing Zhifei Biological Products Company Description
Chongqing Zhifei Biological Products Co., Ltd. engages in the research and development, production, marketing, distribution, import, and export of vaccines in China.
The company offers Recombinant Novel Coronavirus Vaccine (CHO Cell); Recombinant Mycobacterium Tuberculosis Fusion Protein under the Ekear brand; Haemophilus Influenzae Type b Vaccine under the XiFeiBei brand; ACYW135 Meningococcal Polysaccharide Vaccine under the Menwayc brand; Mycobacterium Vaccae for Injection under the Vaccae brand; Meningococcal Group A and Group C Polysaccharide Conjugate Vaccine under the Mening A Con brand; and other developed products.
It also provides cold storage services. Chongqing Zhifei Biological Products Co., Ltd. was founded in 2002 and is based in Chongqing, China.
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7,220 |
| CEO | Lingfeng Jiang |
Contact Details
Address: Building T1 Chongqing, 400020 China | |
| Phone | 86 23 8635 8685 |
| Website | zhifeishengwu.com |
Stock Details
| Ticker Symbol | 300122 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000V20 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Lingfeng Jiang | Vice Chairman of the Board and President |
| Zhen Jing Li CPA | Vice President, Chief Financial Officer and Director |
| Zhijun Wang | Chief Engineer |
| Fei Qin | Vice President, Secretary of Board and Director |
| Yu Zhang | Vice president |
| Zhang Jing | Vice President |
| Jie Shao | Vice President |
| Hong Fan | Vice President |